Immunochemistry reagents and supplies
Ended Purchase Order Awarded Last action
- Contract number
- W91YTZ20P0297
- Awardee
-
Diasorin Inc. UEI FGK2QR959BV5 Part of Diasorin S.P.A.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $818,943
Award facts
- Opportunity
-
- Immuno Analyzers, Reagents and Supplies Special Notice · W91YTZ20R0106 · Posted Sep 21, 2020
- Immuno Analyzers, Reagents and Supplies Award Notice · Posted Oct 14, 2020
- Contract value 88% obligated
- $929,972.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Benning, GA 31905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$111,029 | |
| Funding Only Action | -$55,790 | |
| Funding Only Action | $208,197 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$48,952 | |
| Funding Only Action | $2,520 | |
| Funding Only Action | $205,997 | |
| Exercise an Option | $0 | |
| Funding Only Action | $206,000 | |
| Exercise an Option | $0 | |
| Funding Only Action | $206,000 | |
| Exercise an Option | $0 | |
| Funding Only Action | $206,000 | |
| Original award | $0 |
Show all 14
About this award
The Defense Health Agency awarded a $929,972 firm fixed price purchase order to Diasorin Inc. on October 1, 2020, for immunochemistry reagents and supplies to support operations at Fort Moore, Georgia through October 31, 2025. This sole source contract, justified under Federal Acquisition Regulation 6.302-1 due to the proprietary nature of Diasorin's analyzers and reagents, provides consumables and supplies for chemiluminescence immunoassay analyzers currently installed at the Martin Army Community Hospital Pathology Department. The contract was awarded without a set-aside designation, reflecting Diasorin's competitive positioning as a specialized supplier of advanced diagnostic testing equipment and services to federal healthcare agencies.
Diasorin Inc., a Minnesota-based subsidiary of Italian firm Diasorin S.P.A., specializes in providing diagnostic testing solutions including LIAISON XL and XS analyzers for infectious disease testing and immunochemistry applications. The company maintains an established relationship with the Defense Health Agency and other federal healthcare entities through multiple indefinite delivery contracts and General Services Administration schedules. This award supports the Army Medical Command's pathology operations and contributes to the company's broader portfolio of federal healthcare diagnostics contracts, which have historically ranged from $15,000 to over $600,000 in individual task order values.
Quick answers
Who was awarded contract W91YTZ20P0297?
W91YTZ20P0297 was awarded to Diasorin Inc. by Medical Command (Department of the Army) on October 1, 2020.
How much is contract W91YTZ20P0297 worth?
The government has obligated $818,943 on W91YTZ20P0297. Its current value, with exercised options, is $929,972.
Which agency awarded contract W91YTZ20P0297?
Medical Command (Department of the Army) awarded W91YTZ20P0297, with funding from Defense Health Agency (Department of Defense).
Was contract W91YTZ20P0297 competed?
The extent of competition for W91YTZ20P0297 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award